Research Archive — Page 40 of 139
-
December 4, 2023
Study links gene network and pancreatic beta cell defects to Type 2 diabetes
A comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes. -
November 29, 2023
Nonprofits support quest to cure childhood epilepsy
Monica Joanna Elnekaveh was doing everything she could to learn what was causing her 18-month-old daughter’s developmental issues. Her relentless quest to find answers eventually led her to Vanderbilt investigative neurologist Jing-Qiong (Katty) Kang, MD, PhD. -
November 21, 2023
Commensal gut bacterium protects from severe intestinal infection
The commensal bacterium Turicibacter sanguinis could be used to protect against severe intestinal infections, Vanderbilt researchers discovered. -
November 21, 2023
VUMC scientists discover key step to kidney fibrosis
Researchers at Vanderbilt University Medical Center for the first time have shown that activation of the epidermal growth factor receptor (EGFR) is essential for the development of kidney fibrosis, tissue scarring following injury that can lead to kidney failure. -
November 17, 2023
Study validates use of VUMC suicide risk model in Navy primary care
A Vanderbilt study found that automated suicide risk prediction models operating on electronic health records could help clinical teams efficiently identify patients for face-to-face suicide risk screening and prevention. -
November 17, 2023
Tumor antigens key to improving cancer immunotherapy: study
An undergraduate artist worked with the Vanderbilt researchers to create this oil painting, inspired the research. They are working to better design immune therapies that attack tumors without also attacking healthy normal tissue in patients. -
November 16, 2023
Nasty microbe H. pylori has Achilles’ heel
Vanderbilt researchers found that an H. pylori enzyme is essential for colonization of the stomach, suggesting it as a promising therapeutic target for H. pylori infection.